These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 38219142)
1. Predictive factors that influence the clinical efficacy of umbilical cord-derived mesenchymal stromal cells in the treatment of type 2 diabetes mellitus. Wang Y; Chen H; Li Y; Hao H; Liu J; Chen Y; Meng J; Zhang S; Gu W; Lyu Z; Zang L; Mu Y Cytotherapy; 2024 Mar; 26(3):311-316. PubMed ID: 38219142 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring. Zang L; Li Y; Hao H; Liu J; Zhang Q; Gao F; Wang H; Chen Y; Gu W; Du J; Meng J; Zhang S; Lyu Z; Dou J; Mu Y Stem Cells Transl Med; 2023 Dec; 12(12):775-782. PubMed ID: 37738447 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial. Zang L; Li Y; Hao H; Liu J; Cheng Y; Li B; Yin Y; Zhang Q; Gao F; Wang H; Gu S; Li J; Lin F; Zhu Y; Tian G; Chen Y; Gu W; Du J; Chen K; Guo Q; Yang G; Pei Y; Yan W; Wang X; Meng J; Zhang S; Ba J; Lyu Z; Dou J; Han W; Mu Y Stem Cell Res Ther; 2022 May; 13(1):180. PubMed ID: 35505375 [TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]). Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553 [TBL] [Abstract][Full Text] [Related]
5. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes. Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696 [TBL] [Abstract][Full Text] [Related]
6. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. Yin Y; Hao H; Cheng Y; Gao J; Liu J; Xie Z; Zhang Q; Zang L; Han W; Mu Y Int Immunopharmacol; 2018 Jul; 60():235-245. PubMed ID: 29778021 [TBL] [Abstract][Full Text] [Related]
7. One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study. Lu J; Shen SM; Ling Q; Wang B; Li LR; Zhang W; Qu DD; Bi Y; Zhu DL Stem Cell Res Ther; 2021 Jun; 12(1):340. PubMed ID: 34112266 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation. Zhang YC; Liu W; Fu BS; Wang GY; Li HB; Yi HM; Jiang N; Wang G; Zhang J; Yi SH; Li H; Zhang Q; Yang Y; Chen GH Cytotherapy; 2017 Feb; 19(2):194-199. PubMed ID: 27964826 [TBL] [Abstract][Full Text] [Related]
9. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion. Cai J; Wu Z; Xu X; Liao L; Chen J; Huang L; Wu W; Luo F; Wu C; Pugliese A; Pileggi A; Ricordi C; Tan J Diabetes Care; 2016 Jan; 39(1):149-57. PubMed ID: 26628416 [TBL] [Abstract][Full Text] [Related]
10. Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice. Li B; Cheng Y; Yin Y; Xue J; Yu S; Gao J; Liu J; Zang L; Mu Y Cytotherapy; 2021 Jun; 23(6):510-520. PubMed ID: 33736932 [TBL] [Abstract][Full Text] [Related]
11. Glycemic control by umbilical cord-derived mesenchymal stem cells promotes effects of fasting-mimicking diet on type 2 diabetic mice. Zhao N; Gao YF; Bao L; Lei J; An HX; Pu FX; Cheng RP; Chen J; Ni H; Sui BD; Ji FP; Hu CH Stem Cell Res Ther; 2021 Jul; 12(1):395. PubMed ID: 34256832 [TBL] [Abstract][Full Text] [Related]
12. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial. Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390 [TBL] [Abstract][Full Text] [Related]
13. Pilot study of umbilical cord-derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis. Wang L; Li J; Liu H; Li Y; Fu J; Sun Y; Xu R; Lin H; Wang S; Lv S; Chen L; Zou Z; Li B; Shi M; Zhang Z; Wang FS J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():85-92. PubMed ID: 23855301 [TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis. Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936 [TBL] [Abstract][Full Text] [Related]
15. Reduction of Graft-versus-Host-Disease in NOD.Cg-Prkdc Hansen M; Stahl L; Heider A; Hilger N; Sack U; Kirschner A; Cross M; Fricke S Transplant Cell Ther; 2021 Aug; 27(8):658.e1-658.e10. PubMed ID: 33964513 [TBL] [Abstract][Full Text] [Related]
16. Decitabine assists umbilical cord-derived mesenchymal stem cells in improving glucose homeostasis by modulating macrophage polarization in type 2 diabetic mice. Gao J; Cheng Y; Hao H; Yin Y; Xue J; Zhang Q; Li L; Liu J; Xie Z; Yu S; Li B; Han W; Mu Y Stem Cell Res Ther; 2019 Aug; 10(1):259. PubMed ID: 31426846 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data. He J; Kong D; Yang Z; Guo R; Amponsah AE; Feng B; Zhang X; Zhang W; Liu A; Ma J; O'Brien T; Cui H PLoS One; 2021; 16(3):e0247662. PubMed ID: 33705413 [TBL] [Abstract][Full Text] [Related]
19. Human Umbilical Cord Mesenchymal Stem Cells Improve Ovarian Function in Chemotherapy-Induced Premature Ovarian Failure Mice Through Inhibiting Apoptosis and Inflammation via a Paracrine Mechanism. Deng T; He J; Yao Q; Wu L; Xue L; Wu M; Wu D; Li C; Li Y Reprod Sci; 2021 Jun; 28(6):1718-1732. PubMed ID: 33751459 [TBL] [Abstract][Full Text] [Related]
20. Thermosensitive and injectable chitosan-based hydrogel embedding umbilical cord mesenchymal stem cells for β-cell repairing in type 2 diabetes mellitus. Yang J; Liu Y; Deng G; Feng J; Yu H; Cen X; Li H; Huang Q; Zhang H Int J Biol Macromol; 2024 Nov; 279(Pt 4):135546. PubMed ID: 39265905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]